Nitin Kaushal insider trades: Viemed Healthcare (VMD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nitin reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | VMD | ↓ Sell | 7,048 | $6.91 | $49K | Direct | Jul 1, 2025 (1d) |
| Jun 27, 2025 | VMD | ↓ Sell | 42,952 | $7.01 | $301K | Direct | Jun 30, 2025 (3d) |
| Nov 26, 2024 | VMD | ↓ Sell | 30,000 | $8.68 | $260K | Direct | Nov 26, 2024 (0d) |
| Nov 20, 2024 | VMD | ↓ Sell | 30,000 | $8.53 | $256K | Direct | Nov 21, 2024 (1d) |
| Nov 13, 2024 | VMD | ↓ Sell | 60,000 | $9.52 | $571K | Direct | Nov 13, 2024 (0d) |
| Mar 17, 2023 | VMD | ↓ Sell | 12,087 | $13.43 | $162K | Direct | Mar 20, 2023 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VMD insiders
Open-market trades in the last 12 months
About Nitin Kaushal's insider trades
Nitin Kaushal is a director at Viemed Healthcare (VMD). Since Mar 17, 2023, Nitin has reported no open-market purchases and 6 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (13 filings), grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.